Chembio Diagnostics, Inc. and its subsidiaries engage in the development, manufacture, and marketing of lateral flow rapid diagnostic tests for detecting infectious diseases in the United States and internationally. The company primarily offers SURE CHECK HIV, HIV 1/2 STAT-PAK, and HIV 1/2 STAT-PAK Dipstick rapid tests for use in the diagnosis of infectious diseases and other conditions in humans and animals, as well as for Chagas disease and Lyme disease. It is also developing rapid tests for other infectious diseases, such as rapid tests for human and veterinary tuberculosis. Chembio Diagnostics sells its tests to medical laboratories and hospitals, governmental and public health entities, nongovernmental organizations, medical professionals, and retail establishments in Africa, South America, and Asia. The company was founded in 1985 and is based in Medford, New York.
Management
Documents
CEMI has not yet provided us with management data. Please check back again later.
Chembio Diagnostics, Inc.
